SMO and basal cell carcinoma: Genetic alterations in the Hh pathway leading to constitutive activation of Hh signaling, such as inactivating mutations of PTCH1 or gain-of-function mutations in SMO, are linked to the development of several human malignancies such as basal cell carcinoma (BCC), medulloblastoma, and rhabdomyosarcoma [4,5].